Celsius Holdings Inc (NASDAQ:CELH) shares are climbing Wednesday afternoon as traders lean into a rebound attempt after a prolonged downtrend, with the stock pushing back above key short-term moving averages.Here is a closer look at the drivers fueling the market’s momentum this Wednesday afternoon.
Celsius Holdings shares are climbing with conviction. What’s fueling CELH momentum?
What Is Driving CELH’s Recent Price Movement?With markets open and index performance mixed, CELH’s move reads more like a technical "catch-up" bounce than a broad sector-driven lift, especially given how far the stock remains below its longer-term trend gauges. In other words, buyers are stepping in as the chart improves at the margin, even while the growth-heavy Nasdaq is sliding.Market breadth is constructive (7 sectors advancing and an advance/decline ratio of 1.8), which can help risk appetite even on a day when mega-cap pressure drags the Nasdaq lower. Consumer Staples is mid-pack today, so CELH’s outsized move looks stock-specific rather than a rising-tide effect.CELH Stock: Key Levels and Momentum IndicatorsCELH is now trading 9.3% above its 20-day SMA ($29.13) and 3.8% above its 50-day SMA ($30.65), which supports the idea that the near-term trend is trying to turn up. The bigger-picture trend is still a headwind, with the stock trading 12% below its 100-day SMA ($36.18) and 27.3% below its 200-day SMA ($43.77).Momentum is improving: the MACD is above its signal line and the histogram is positive, which typically signals that downside pressure is easing versus the prior downswing. MACD is useful here because it helps confirm whether a bounce is gaining traction or fading as it runs into overhead supply.The longer-term damage still matters, including the death cross that printed in March (50-day SMA below the 200-day SMA), which often keeps rallies choppy until price can reclaim longer moving averages. From a swing perspective, the stock’s recent swing low in June and swing high in April frame the current move as a rebound attempt inside a broader 12-month decline of 30.91%.
